Cinaciguat
- N ° de catalogue:A855873
- N ° CAS. : 329773-35-5
- Formule moléculaire:C36H39NO5
- Masse moléculaire: 565.70
Remarque*
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Enquête en vrac
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
détails du produit
Numero CAS | 329773-35-5 | Apparence | White powder |
Numéro de catalogue | A855873 | Numéro MDL | MFCD18782678 |
Formule moléculaire | C36H39NO5 | Masse moléculaire | 565.70 |
Point d'ébullition | Point de fusion | ||
Point de rupture | Densité | ||
Synonymes | 2-(((4-carboxybutyl)(2-((4-phenethylbenzyl)oxy)phenethyl)amino)methyl)benzoic acid;Cinaciguat | ||
Condition de stockage | Store in a tightly closed container,in a cool and dry place |
sécurité
Pictogramme SGH | |||
Mot de signal | Warning | Numéro UN | |
Mentions de danger | H302-H315-H319-H335 | Classe | |
Conseils de prudence | P261-P305+P351+P338 | Groupe d'emballage |
La description
Cinaciguat, also known as BAY582667 or BAY58-2667, is a soluble guanylate cyclase activator. Cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus. Cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats. Cinaciguat prevents neointima formation after arterial injury by decreasing vascular smooth muscle cell migration and proliferation. |